Pediatric vaccines market, doses, immunization, cases and forecast worldwide analysis
Upcoming SlideShare
Loading in...5
×
 

Pediatric vaccines market, doses, immunization, cases and forecast worldwide analysis

on

  • 629 views

Renub Research (http://www.renub.com/report/pediatric-vaccines-market-doses-immunization-cases-and-forecast-worldwide-analysis-86) has announced the addition of the "Pediatric Vaccines Market, Doses, ...

Renub Research (http://www.renub.com/report/pediatric-vaccines-market-doses-immunization-cases-and-forecast-worldwide-analysis-86) has announced the addition of the "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis" report to its offering
Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during 2012 – 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7, Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution.

It is predicted that Pediatric proprietary vaccines will lead the segment with little less than 60% market share by 2015.The combinations & boosters and enhanced pediatric vaccines market are expected to show stagnant growth in future due to lower margins and the mature nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines control 55% of the market share in 2011.

In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown decline continuously from the year 2001 till 2011. Polio remains endemic merely in three countries and the good news is that India has not reported a single case from the past two years and on the verge of being called a polio free country.

DTP are the most utilized vaccines in the pediatric vaccines market which contributed less than 10,000 Million doses in 2011. Pediatric Hepatitis and Polio vaccines are also mostly used vaccines which consumed more than 6,000 Million doses in 2011. In case of Rotavirus vaccine although the price of Rotavirus vaccine has declined but still its present prices are expensive than other pediatric vaccines. However despite all the impediments pediatric vaccines industry is expected to remain highly active in the future, fueled by the encouragement and financing from governments and other health organizations.

Renub Research report titled "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis” talks about the pediatric vaccines. The report provides information on all the Nine (9) Pediatric Vaccines Market, Doses, Immunization and Number of Cases by region in the world. This report covers in detail all aspects of past, present and future scenario. This report provides market landscape and market share information of the Pediatric Combinations & Booster, Pediatric Enhanced Combination and Pediatric Proprietary Vaccines Market. The report also entails major factors driving the pediatric vaccine market and challenges of pediatric vaccine market.

Statistics

Views

Total Views
629
Slideshare-icon Views on SlideShare
629
Embed Views
0

Actions

Likes
0
Downloads
15
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Pediatric vaccines market, doses, immunization, cases and forecast worldwide analysis Pediatric vaccines market, doses, immunization, cases and forecast worldwide analysis Document Transcript

    • Pediatric Vaccines Market, Doses, Immunization,Cases and Forecast: Worldwide AnalysisRenub Researchwww.renub.comPublished: December, 2012Copyright © 2012 Renub Research – All Rights Reserved
    • © Renub Research Page 2 of 18Pediatric Vaccines Market AnalysisWorldwide pediatric vaccine market has been growing rapidly over the last five years as it hasdoubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine marketis expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during2012 – 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7,Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution.It is predicted that Pediatric proprietary vaccines will lead the segment with little less than60% market share by 2015.The combinations & boosters and enhanced pediatric vaccinesmarket are expected to show stagnant growth in future due to lower margins and the maturenature of these markets. Pneumococcal, DTP and Varicella together all these three vaccinescontrol 55% of the market share in 2011.In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have showndecline continuously from the year 2001 till 2011. Polio remains endemic merely in threecountries and the good news is that India has not reported a single case from the past twoyears and on the verge of being called a polio free country.DTP are the most utilized vaccines in the pediatric vaccines market which contributed lessthan 10,000 Million doses in 2011. Pediatric Hepatitis and Polio vaccines are also mostly usedvaccines which consumed more than 6,000 Million doses in 2011. In case of Rotavirus vaccinealthough the price of Rotavirus vaccine has declined but still its present prices are expensivethan other pediatric vaccines. However despite all the impediments pediatric vaccinesindustry is expected to remain highly active in the future, fueled by the encouragement andfinancing from governments and other health organizations.Renub Research report titled "Pediatric Vaccines Market, Doses, Immunization, Cases andForecast: Worldwide Analysis” talks about the pediatric vaccines. The report providesinformation on all the Nine (9) Pediatric Vaccines Market, Doses, Immunization and Number ofCases by region in the world. This report covers in detail all aspects of past, present andfuture scenario. This report provides market landscape and market share information of thePediatric Combinations & Booster, Pediatric Enhanced Combination and Pediatric Proprietary
    • © Renub Research Page 3 of 18Vaccines Market. The report also entails major factors driving the pediatric vaccine marketand challenges of pediatric vaccine market.Pediatric Vaccines Covered in this Report are as follows:Measles, Mumps & Rubella (MMR) Vaccines, Haemophilus Influenzae Type B (HIB) Vaccines,Polio Vaccines, Diphtheria, Tetanus & Pertussis (Combos) Vaccines, Pneumococcal VaccinesRotavirus Vaccines, Hepatitis Pediatric Vaccines, Varicella/Chicken Pox Vaccines and OtherPediatric VaccinesAll the Pediatric Vaccines in this Report have been Studied from Four View Points: Number of Cases Reported for all 9 Pediatric Diseases by Region from 2001 to 2011 Number of Doses Reported and Forecast for all 9 Pediatric Vaccine from 2005 to 2015 Immunization Coverage for all 9 Pediatric Vaccines and Forecast from 2005 to 2015 Market Size for all 9 Pediatric Vaccines and Forecast from 2005 to 2015Key Topics Covered in the Report Worldwide – Pediatric Vaccines Market and Forecast (2006 - 2015) Worldwide – Pediatric Vaccines Market Share and Forecast (Sector wise) (2005 - 2015) Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 - 2015) By Sector (All 9) – Pediatric Vaccines Market and Forecast (2005 - 2015) By Region - Pediatric Disease Cases (2001 – 2011) Pediatric Vaccines Doses and Forecast (2005 – 2015) Pediatric Vaccines Immunization Coverage and Forecast (2005 - 2015) All 9 Pediatric Vaccines Market and Forecast (2005 - 2015) Growth Drivers of Pediatric Vaccines Market Challenges of Pediatric Vaccines Market
    • © Renub Research Page 4 of 18Data SourcesThis report is built using data and information sourced from proprietary databases, primaryand secondary research and in-house analysis by Renub Research team of industry experts.Primary sources include industry surveys and telephone interviews with industry experts.Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals,White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books,Industry Portals, Industry Associations and access to more than 100 paid databases.
    • © Renub Research Page 5 of 18About UsRReennuubb RReesseeaarrcchh is a leading Market Research and Information Analysis Company withcenters at Noida India and Roswell USA. We have long-term experience especially ininternational Business-to-Business Researches, Surveys, Business and Consulting. Throughoutthe years we have acquired expertise in most market sectors, including InformationTechnology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services(Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG,Consumer Goods, Logistics, Governmental, Social, and Others.Our core team is comprised of an experienced people holding graduate, post graduate andPh.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, InformationTechnology, Environmental Science and many more. Our research help make the businessdecisions: on strategy, organization, operations, technology, mergers & acquisitions etc. Wesupport many blue chip companies by providing them findings and perspectives across a widerange of markets. Our research reports offer a blend of information insight, analysis andforecasting that is essential in today’s ultra-competitive markets.For more information on us or to view any of our sample work you canmail us at info@renub.com
    • © Renub Research Page 6 of 18PublishedByRReennuubb RReesseeaarrcchhA–116B, Sector–27Noida – 201301Phone: +91-120-421-9822, 254-5750 (India)+1-678-302-0700 (USA)Fax : +91-120-424-9780Email: info@renub.comwww.renub.com© Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide AnalysisRenub Research, 2012Edition 1.0All rights reserved. This publication is protectedby copyright. No part of it may be reproduced, storedin a retrieval system or transmitted, in any form or byany means, electronic mechanical, photocopying,recording or otherwise without the prior writtenpermission of the publishers
    • © Renub Research Page 7 of 18Table of Contents1. Executive Summary2. Worldwide Pediatric Vaccines Market and Forecast (2006 – 2015)3. Worldwide – Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 – 2015)4. Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 – 2015)5. By Sector – Pediatric Vaccines Market and Forecast (2005 – 2015)5.1 Worldwide – Pediatric Combinations & Boosters Vaccines Market5.2 Worldwide – Pediatric Enhanced Combinations Vaccines Market5.3 Worldwide – Pediatric Proprietary Vaccines Market6. Major Pediatric Vaccines Cases, Doses, Immunization Coverage, Market and Forecast6.1 Measles, Mumps & Rubella (MMR) Vaccines and Forecast (2005 – 2015)6.1.1 Number of Measles, Mumps & Rubella Cases (2001 – 2011)6.1.2 Number of Measles, Mumps & Rubella (MMR) Vaccines Doses6.1.3 Immunization Coverage of Measles, Mumps & Rubella (MMR) Vaccines6.1.4 Market Size of Measles, Mumps & Rubella (MMR) Vaccines6.2 Haemophilus Influenzae Type B (HIB) Vaccines and Forecast (2005 – 2015)6.2.1 Number of Haemophilus Influenzae Type B (HIB) Meningitis Cases (2001 – 2011)6.2.2 Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses6.2.3 Immunization Coverage of Haemophilus Influenzae Type B (HIB) Vaccines6.2.4 Market Size of Haemophilus Influenzae Type B (HIB) Vaccines6.3 Polio Vaccines and Forecast (2005 – 2015)6.3.1 Number of Polio Cases (2001 – 2011)6.3.2 Number of Polio Vaccines Doses6.3.3 Immunization Coverage of Polio Vaccines6.3.4 Market Size of Polio Vaccines6.4 Diphtheria, Tetanus & Pertussis (Combos) Vaccines and Forecast (2005 – 2015)6.4.1 Number of Diphtheria, Tetanus & Pertussis (DTP) Cases (2001 – 2011)6.4.2 Number of Diphtheria, Tetanus & Pertusis (DTP) Vaccines Doses6.4.3 Immunization Coverage of Diphtheria, Tetanus & Pertusis (DTP) Vaccines6.4.4 Market Size of Diphtheria, Tetanus & Pertussis (Combos) Vaccines6.5 Pneumococcal Vaccines and Forecast (2005 – 2015)
    • © Renub Research Page 8 of 186.5.1 Number of Pneumococcal Cases (2000)6.5.2 Number of Pneumococcal Vaccines Doses6.5.3 Immunization Coverage of Pneumococcal Vaccines6.5.4 Market Size of Pneumococcal Vaccines6.6 Rotavirus Vaccine and Forecast (2006 – 2015)6.6.1 Number of Rotavirus Cases (2008 & 2009)6.6.2 Number of Rotavirus Vaccines Doses6.6.3 Immunization Coverage of Rotavirus Vaccines6.6.4 Market Size of Rotavirus Vaccine6.7 Hepatitis Pediatric Vaccines and Forecast (2005 – 2015)6.7.1 Number of Hepatitis Pediatric Vaccines Doses6.7.2 Immunization Coverage of Hepatitis Pediatric Vaccines6.7.3 Market Size of Hepatitis Pediatric Vaccines6.8 Varicella/Chicken Pox Vaccines and Forecast (2005 – 2015)6.8.1 Number of Varicella/Chicken Pox Vaccines Doses6.8.2 Market Size of Varicella/Chicken Pox Vaccines6.9 Other Pediatric Vaccines and Forecast (2005 – 2015)6.9.1 Market Size of Other Pediatric Vaccines7. Growth Drivers of Pediatric Vaccines Market7.1 Reduced Price on Rotavirus Vaccines: Enough to Facilitate Growth but More Still Needs To BeDone Error! Bookmark not defined.7.1.1 Rotavirus Vaccine Introduction7.1.2 Financial Challenges7.1.3 Cost Effective7.1.4 Future Steps7.1.5 Conclusion7.2 GAVI Model Increases Vaccine Manufacturers7.2.1 The Partnership Model7.2.2 The Business Model7.3 WHO Global Vaccine Action Plan (2011 - 2020)8. Challenges of Pediatric Vaccine Market8.1 Roadblocks in Expanding Access to Newer Pediatric Vaccines8.2 Impediment in Pediatric Vaccine Research & Development
    • © Renub Research Page 9 of 188.3 Barriers to New Entrants in the Pediatric Vaccines Market
    • © Renub Research Page 10 of 18List of FiguresFigure 2-1: Worldwide – Pediatric Vaccines Market (Million US$), 2006 – 2011Figure 2-2: Worldwide – Forecast for Pediatric Vaccines Market (Million US$), 2012 – 2015Figure 3-1: Worldwide (Sector wise) – Pediatric Vaccines Market Share (Percent), 2005 – 2011Figure 3-2: Worldwide (Sector wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 –2015Figure 5-1: Worldwide – Pediatric Combinations & Boosters Vaccines Market (Million US$), 2005 – 2011Figure 5-2: Worldwide – Forecast for Pediatric Combinations & Boosters Vaccines Market (Million US$),2012 – 2015Figure 5-3: Worldwide – Pediatric Enhanced Combinations Vaccines Market (Million US$), 2005 – 2011Figure 5-4: Worldwide – Forecast for Pediatric Enhanced Combinations Vaccines Market (Million US$),2012 – 2015Figure 5-5: Worldwide – Pediatric Proprietary Vaccines Market (Million US$), 2005 – 2011Figure 5-6: Worldwide – Forecast for Pediatric Proprietary Vaccines Market (Million US$), 2012 – 2015Figure 6-1: Worldwide – Number of MMR Vaccines Doses (Million Doses), 2005 – 2011Figure 6-2: Worldwide – Forecast for Number of MMR Vaccines Doses (Million Doses), 2012 – 2015Figure 6-3: Worldwide – Immunization Coverage of MMR Vaccines Doses (Million Doses), 2005 – 2011Figure 6-4: Worldwide – Forecast for Immunization Coverage of MMR Vaccines Doses (Million Doses),2012 – 2015Figure 6-5: Worldwide – Measles, Mumps & Rubella Vaccines Market (Million US$), 2005 – 2011Figure 6-6: Worldwide – Forecast for Measles, Mumps & Rubella Vaccines Market (Million US$), 2012 –2015Figure 6-7: Worldwide – Haemophilus Influenzae Type B Vaccine Introduction in High & Low-IncomeCountries, 1980 – 2010Figure 6-8: Worldwide – Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses),2005 – 2011Figure 6-9: Worldwide – Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines(Million Doses), 2012 – 2015Figure 6-10: Worldwide – Immunization Coverage of Haemophilus Influenzae Type B Vaccines (MillionDoses), 2005 – 2011Figure 6-11: Worldwide – Forecast for Immunization Coverage of Haemophilus Influenzae Type BVaccines (Million Doses), 2012 – 2015Figure 6-12: Worldwide – Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2005 –2011Figure 6-13: Worldwide – Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (MillionUS$), 2012 – 2015
    • © Renub Research Page 11 of 18Figure 6-14: Worldwide – Number of Doses of Polio Vaccines (Million Doses), 2005 – 2011Figure 6-15: Worldwide – Forecast for Number of Doses of Polio Vaccines (Million Doses), 2012 – 2015Figure 6-16: Worldwide – Immunization Coverage of Polio Vaccines (Million Doses), 2005 – 2011Figure 6-17: Worldwide – Forecast for Immunization Coverage of Polio Vaccines (Million Doses), 2012 –2015Figure 6-18: Worldwide – Polio Vaccines Market (Million US$), 2005 – 2011Figure 6-19: Worldwide – Forecast for Polio Vaccines Market (Million US$), 2012 – 2015Figure 6-20: Worldwide – Number of Doses of DTP Vaccines (Million Doses), 2005 – 2011Figure 6-21: Worldwide – Forecast for Number of Doses of DTP Vaccines (Million Doses), 2012 – 2015Figure 6-22: Worldwide – Immunization Coverage of DTP Vaccines (Million Doses), 2005 – 2011Figure 6-23: Worldwide – Forecast for Immunization Coverage of DTP Vaccines (Million Doses), 2012 –2015Figure 6-24: Worldwide – Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2005– 2011Figure 6-25: Worldwide – Forecast for Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market(Million US$), 2012 – 2015Figure 6-26: Worldwide – Pneumococcal Vaccine Pipeline, 2000 – 2025Figure 6-27: Worldwide – Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 – 2011Figure 6-28: Worldwide – Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses), 2012– 2015Figure 6-29: Worldwide – Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2010 –2011Figure 6-30: Worldwide – Forecast for Immunization Coverage of Pneumococcal Vaccines (MillionDoses), 2012 – 2015Figure 6-31: Worldwide – Pneumococcal Vaccines Market (Million US$), 2005 – 2011Figure 6-32: Worldwide – Forecast for Pneumococcal Vaccines Market (Million US$), 2012 – 2015Figure 6-33: Worldwide – Number of Doses of Rotavirus Vaccines (Million Doses), 2010 – 2011Figure 6-34: Worldwide – Forecast for Number of Doses of Rotavirus Vaccines (Million Doses), 2012 –2015Figure 6-35: Worldwide – Immunization Coverage of Rotavirus Vaccines (Million Doses), 2010 – 2011Figure 6-36: Worldwide – Forecast for Immunization Coverage of Rotavirus Vaccines (Million Doses),2012 – 2015Figure 6-37: Worldwide – Rotavirus Vaccine Market (Million US$), 2006 – 2011Figure 6-38: Worldwide – Forecast for Rotavirus Vaccine Market (Million US$), 2012 – 2015Figure 6-39: Worldwide – Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2005 – 2011Figure 6-40: Worldwide – Forecast for Number of Doses of Hepatitis Pediatric Vaccines (Million Doses),2012 – 2015
    • © Renub Research Page 12 of 18Figure 6-41: Worldwide – Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2005 –2011Figure 6-42: Worldwide – Forecast for Immunization Coverage of Hepatitis Pediatric Vaccines (MillionDoses), 2012 – 2015Figure 6-43: Worldwide – Hepatitis B Vaccine Introduction in High & Low-income countries, 1980 – 2010Figure 6-44: Worldwide – Hepatitis Pediatric Vaccines Market (Million US$), 2005 – 2011Figure 6-45: Worldwide – Forecast for Hepatitis Pediatric Vaccines Market (Million US$), 2012 – 2015Figure 6-46: Worldwide – Number of Doses of Varicella Vaccines (Million Doses), 2005 – 2011Figure 6-47: Worldwide – Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2012 –2015Figure 6-48: Worldwide – Varicella Vaccines Market (Million US$), 2005 – 2011Figure 6-49: Worldwide – Forecast for Varicella Vaccines Market (Million US$), 2012 – 2015Figure 6-50: Worldwide – Other Pediatric Vaccines Market (Million US$), 2005 – 2011Figure 6-51: Worldwide – Forecast for Other Pediatric Vaccines Market (Million US$), 2012 – 2015Figure 7-1: Prices of Childhood Vaccines (US$), 2011Figure 7-2: Reduction in Rotavirus Vaccine Prices (US$), May 2011 & April 2012Figure 7-3: Increasing Number of GAVI Suppliers Based in Emerging Markets
    • © Renub Research Page 13 of 18List of TablesTable 4-1: Worldwide (Disease wise) – Pediatric Vaccines Market Share (Percent), 2006 – 2011Table 4-2: Worldwide (Disease wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 –2015Table 6-1: Worldwide (By Geographic Region) – Number of Measles Cases (Number), 2001 – 2011Table 6-2: Worldwide (By Geographic Region) – Number of Mumps Cases (Number), 2001 – 2011Table 6-3: Worldwide (By Geographic Region) – Number of Rubella Cases (Number), 2001 – 2011Table 6-4: Worldwide (By Geographic Region) – Number of Haemophilus Influenzae Type B MeningitisCases (Number), 2001 – 2011Table 6-5: Worldwide (By Geographic Region) – Number of Polio Cases (Number), 2001 – 2011Table 6-6: Worldwide (By Geographic Region) – Number of Diphtheria Cases (Number), 2001 – 2011Table 6-7: Worldwide (By Geographic Region) – Number of nTetanus Cases (Number), 2001 – 2011Table 6-8: Worldwide (By Geographic Region) – Number of tTetanus Cases (Number), 2001 – 2011Table 6-9: Worldwide (By Geographic Region) – Number of Pertusis Cases (Number), 2001 – 2011Table 6-10: Worldwide (By Geographic Region) – Pneumococcal Cases & Death in Children Under 5Years of Age (Number), 2000Table 6-11: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance (Number),2008 – 2009Table 6-12: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance PositiveCases (Number & Percent), 2009Table 7-1: Worldwide – Total Future Deaths Averted through Vaccination (Million), 2011 – 2020Table 7-2: Goal-Level Indicators, 2015 & 2020
    • © Renub Research Page 14 of 18Related ReportsGlobal Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, ImplantableCardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device)Market Forecast, Clinical Trials, M&AWestern Europe (EU-16) In Vitro Diagnostics Market Report & Forecast (2012 – 2015)Asia Medical Tourism Analysis and Forecast to 2015Clinical Chemistry Market Report & Forecast (2012 – 2015): Global AnalysisHepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016Influenza Vaccine Market Opportunities and Challenges: Worldwide ForecastGenetic Testing Market and Forecast - Global Analysis 2010 – 2015USA Cardiovascular Devices Market Trends and Forecast (2010 – 2015)Global Osteoporosis Market & Drugs Analysis 2010 – 2015Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015)Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies &Clinical Trials) to 2017: Global AnalysisAlzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & DrugsAnalysisPersonalized Medicine Market (2010 - 2015) - By Segments, Technologies, Opportunities,Challenges & Future Forecast
    • © Renub Research Page 15 of 18Our Partial List of ClientsBainWAKE Technology Services, Inc.PSS World MedicalRelypsaC&K componentsKonkuk UniversityResoneticsSamsungSEKISUI MEDICAL CO. LTD.Plentyoffish Media INCArthur D Little GmbhMorgan StanleyTakeda Pharmaceutical CorporationHokkai School of CommerceMinistry of Manpower SingaporeGenOmind, LLC.Goldman Sachs & CoNTT Advanced TechnologyTokyo Womens Medical UniversityThe Chemo-Sero-Therapeutic ResearchTrade Council of IcelandJpmorgan, Ets TradingGE Healthcare ITixia communicationsRedbusBecton DickinsonPfizerIntercellSanofi PasteurStanford BurgessPequot CapitalDMITransgene S.A.ixia communicationsToyota Tsusho Amercia Inc.National Health Research InstitutesAbbott Diabetes CareCorning Incorporated - Life SciencesL.E.K. Consulting GmbHSyntironMediVas LLCCredit SuisseDune MedicalQIAGENInje UniversityMapp BiopharmaceuticalInstitute for Information IndustryNorDiag ASARep e Inv Medicas SA deInnogenetics
    • © Renub Research Page 16 of 18Order FormScan and e-mail this page to info@renub.com, alternatively one can also write the ContactInformation in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail toinfo@renub.comFormatReport Title: Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: WorldwideAnalysisSingle User(Email from Publisher)Hard Copy(Mail Delivery)CD – Rom(Mail Delivery)Global Site License(Multiple User License)US$ 1,400 US$ 1,550 US$ 1,500 US$ 2,200For ordering this report: Three easy ways to place your order:1) Order online by Credit Card (Visa, MasterCard, etc.):http://www.renub.com/report/pediatric-vaccines-market-doses-immunization-cases-and-forecast-worldwide-analysis-862) Order by Wire Transfer:http://www.renub.com/report/wiretransfer.aspx?id=86&pid=1325To pay by Wire Transfer, please, fill in your contact details in the form below:
    • © Renub Research Page 17 of 18Bank DetailsAccount Name: Renub ResearchA/C No.: 109102000023296Name of Bank: IDBI Bank Ltd.Swift Code: IBKLINBB010Bank Address: 4thFloorIndian Red Cross Building1 Red Cross RoadOpposite Parliament StreetNew Delhi – 110001IndiaContact InformationFirst Name: Last Name:Email:Job Title:Company:Address:City:Postal/Zip Code:Country:Phone:Mobile:Fax:Report Format:Your message:
    • © Renub Research Page 18 of 183) Order by CheckPlease post the check accompanied by this form, to:Company Address: Renub ResearchA -116BSector -27Noida - 201301Uttar PradeshIndiaPhone: +91-120-421-9822, 424-9780For free Sample copy report or to view any of our sample work please contact us atinfo@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)Follow UsFacebook: http://www.facebook.com/pages/Renub-Research/233380966701090LinkedIn: http://www.linkedin.com/company/renub-researchTwitter: http://twitter.com/RenubResearch